Skip to main content
Premium Trial:

Request an Annual Quote

James Jacobson, John Carrano, Oliver Meek, Robert Pineau, Trena Penney

Premium

Luminex said this week that it has appointed James Jacobson to the new position of vice president and chief scientific officer. Jacobson will be responsible for setting scientific strategy, interacting with worldwide scientific and medical leaders, and advancing xMAP technology awareness. Jacobson will continue in his role as chairman of the Luminex scientific advisory board.

Luminex also said that it has appointed John Carrano to the position of vice president of research and development, and Oliver Meek to the new position of vice president of quality assurance and regulatory affairs.


Artel this week announced the appointment of Robert Pineau to national accounts manager, and the hiring of Trena Penney as marketing representative. The personnel moves were designed to enhance the firm's ability to meet the demand for its new Liquid Delivery Quality Assurance service suite, the company said.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.